{
    "id": 11337,
    "fullName": "KLC1 - ALK",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "KLC1-ALK results from the fusion of KLC1 and ALK, demonstrating transformed ability in culture and tumorigenicity in mice (PMID: 22347464). KLC1-ALK fusions have been identified in lung cancer (PMID: 22347464, PMID: 28607809).",
            "references": [
                {
                    "id": 11199,
                    "pubMedId": 28607809,
                    "title": "Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer: a case report.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28607809"
                },
                {
                    "id": 3594,
                    "pubMedId": 22347464,
                    "title": "KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22347464"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3831,
        "geneSymbol": "KLC1",
        "terms": [
            "KLC1",
            "KLC",
            "KNS2",
            "KNS2A"
        ]
    },
    "variant": "KLC1 - ALK",
    "createDate": "09/03/2015",
    "updateDate": "04/11/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 238,
                "geneSymbol": "ALK",
                "terms": [
                    "ALK",
                    "CD246",
                    "NBLST3"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 13578,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Xalkori (crizotinib) treatment resulted in rapid initial response in a patient with non-small cell lung cancer with brain metastasis harboring KLC1-ALK fusion and MET amplification (PMID: 28607809).",
            "molecularProfile": {
                "id": 29158,
                "profileName": "KLC1 - ALK MET amp"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 11199,
                    "pubMedId": 28607809,
                    "title": "Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer: a case report.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28607809"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 11386,
            "profileName": "KLC1 - ALK",
            "profileTreatmentApproaches": [
                {
                    "id": 17900,
                    "name": "ALK Inhibitor",
                    "profileName": "KLC1 - ALK"
                }
            ]
        },
        {
            "id": 29158,
            "profileName": "KLC1 - ALK MET amp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}